Osteoblasts in prostate cancer metastasis to bone
By C. Logothetis, Sue-Hwa Lin. Nature Reviews. Cancer, 2005
621 citations recorded by the source corpus.
Subfields: Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/bdebbd6ab633657f10ed55c9d12cde0f27ada948
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Pulmonary and Respiratory Medicine
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- Genetics and biology of prostate cancer (2018, background): “…endothelin 1 (ET-1), adrenomedullin, fibroblast growth factors (FGFs), platelet-derived growth factor (PDGF), and bone morphogenetic proteins (BMPs), can stimulate osteoblast activation to form new bone via paracrine signaling (Logothetis and Lin 2005; Guise et al. 2006; Body et al. 2015).”
- Tumor metastasis: mechanistic insights and clinical challenges (2006, background): “Breast and prostate carcinomas and multiple myeloma mestastasize to bone (reviewed in refs”
- Cancer metastasis: building a framework. (2006, background): “Osteoclasts, derived from the monocytic branch of hematopoiesis, can be differentiated and stimulated through the expression of cytokines, including M-CSF, RANKL, IL-6, IL-8, and IL-11 (Boyle et al., 2003).”
- Molecular genetics of prostate cancer: new prospects for old challenges. (2010, background): “Thus, unlike other epithelial tumors that occasionally metastasize to bone, metastatic prostate cancer almost invariably metastasizes to bone, and furthermore displays characteristic osteoblastic rather than osteolytic lesions (Logothetis and Lin 2005).”